Mohammad Hassaan Khan is a Oklahoma City, Oklahoma based male rheumatologist who is specialized in Rheumatology. Active license number of Mohammad Hassaan Khan for Rheumatology is 42381 in Oklahoma. Mohammad Hassaan Khan treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Mohammad Hassaan Khan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
3330 Nw 56th St Ste 305, Oklahoma City, Oklahoma, 73112-4426
Phone:
405-945-4490
Fax:
405-951-2698
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1669026019
NPI Enumeration Date:
24 Jul, 2019
NPI Last Update On:
13 Aug, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mohammad Hassaan Khan are as mentioned below.
License Number
Specialization
State
Status
42381
Rheumatologist
Oklahoma
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3001 Quail Springs Pkwy Fl 5, Oklahoma City, Oklahoma
Zip:
73134-2640
Phone Number:
405-945-4490
Fax Number:
405-951-2698
Patients can reach Mohammad Hassaan Khan at 3330 Nw 56th St Ste 305, Oklahoma City, Oklahoma or can call to book an appointment on 405-945-4490. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.